BOTANIX PHARMA LTD ORDINARY (BOT) Short Interest
BOTANIX PHARMA LTD ORDINARY (ASX:BOT) had 0.63% of shares reported as short positions as of 26 June 2026, representing 17,133,248 shares. BOTANIX PHARMA LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
BOT
Botanix Pharmaceuticals
Pharmaceuticals, Biotechnology & Life Sciences
Botanix Pharmaceuticals is an Australian clinical dermatology company focused on developing and commercializing innovative treatments for common skin diseases. Their lead product candidate is Sofdra, a potential treatment for primary axillary hyperhidrosis, and they are also developing other products for acne and atopic dermatitis.
Pharmaceuticals
Biotechnology
Life Sciences
ASX
Shorted
short percentage0.63%
reported shorts17.1M
shares on issue2.734B